Cohere Health, a clinical intelligence company, has secured $90 million in Series C funding to accelerate the growth of its clinical intelligence platform for health plans and risk-bearing providers.
Here are five things to know:
- The round was led by Temasek, with participation from Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital and Polaris Partners. This brings the company’s total funding to $200 million, according to a May 14 press release.
- The new capital will support scaling the Cohere Unify platform, expanding to new clinical use cases, and investing in AI-powered product development.
- Cohere Unify modernizes utilization management by integrating real-time provider performance data, automating prior authorizations, and supporting clinical decision-making with precision insights.
- The company processes over 12 million prior authorization requests annually for more than 600,000 providers nationwide.
- Cohere’s platform enables up to 90% of requests to be auto-approved, helping reduce provider burden and expedite patient care.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
